Urgent thyroidectomy for amiodarone-induced thyrotoxicosis – safety and long-term cardiac outcome

Background Amiodarone-induced thyrotoxicosis is a therapeutic challenge, particularly in patients with severe underlying cardiac comorbidities. In refractory cases, urgent thyroidectomy provides definitive treatment, but data on perioperative outcomes and cardiac function remain limited. Methods Retrospective cohort study of all patients undergoing total thyroidectomy for amiodarone-induced thyrotoxicosis between 2011 and 2024 at a tertiary center. Clinical, biochemical, perioperative, and cardiac data were collected from hospital records and the EUROCRINE ® registry. Outcomes included perioperative morbidity, one-year mortality and changes in left ventricular ejection fraction. Results Thirty-four patients (median [IQR] age 63.5 [52.8-71.0] years, 79.4% male) with new-onset amiodarone-induced thyrotoxicosis underwent total thyroidectomy after 68.0 [42.5–95.8] days of medical treatment. Refractory thyrotoxicosis (85.3%) and worsening heart failure (14.7%) were the main indications. At the time of surgery, 82.4% had persistent overt thyrotoxicosis. Surgical morbidity was low: one transient recurrent laryngeal nerve palsy, four cases of transient hypoparathyroidism and no bleeding or wound infection occurred. One-year mortality was 2.9%: one patient died from unrelated causes. Median preoperative left ventricular ejection fraction was 41.0 [28.3-54.4]%. Paired analysis showed no significant differences between baseline, prior to the onset of amiodarone-induced thyrotoxicosis, and postoperative left ventricular ejection fraction, though patients with preserved baseline function (≥50%) experienced a significant decline following the onset of amiodarone-induced thyrotoxicosis (p = 0.03 1 ). Conclusion Thyroidectomy represents a valuable treatment option for refractory amiodarone-induced thyrotoxicosis, with low morbidity and mortality in this cohort. Exploratory analyses indicate that left ventricular ejection fraction remains broadly stable relative to baseline following resolution of thyrotoxicosis. However, in patients with preserved baseline ejection fraction, cardiac function declined significantly during the thyrotoxic state.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-18
DOI
https://doi.org/10.3389/fendo.2026.1981701
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Urgent thyroidectomy for amiodarone-induced thyrotoxicosis – safety and long-term cardiac outcome

Markus Köster, Thomas Clerici, Urs Pietsch, Roman Brenner et al.
Frontiers in Endocrinology
Thyroid Disorders and Treatments
article

Urgent thyroidectomy for amiodarone-induced thyrotoxicosis – safety and long-term cardiac outcome

Markus Köster, Thomas Clerici, Urs Pietsch, Roman Brenner, Ushanthan Uthayanan, Barbara Bischofberger-Baumann, Stefan Bilz, Frida Renström
article en

Abstract

Background Amiodarone-induced thyrotoxicosis is a therapeutic challenge, particularly in patients with severe underlying cardiac comorbidities. In refractory cases, urgent thyroidectomy provides definitive treatment, but data on perioperative outcomes and cardiac function remain limited. Methods Retrospective cohort study of all patients undergoing total thyroidectomy for amiodarone-induced thyrotoxicosis between 2011 and 2024 at a tertiary center. Clinical, biochemical, perioperative, and cardiac data were collected from hospital records and the EUROCRINE ® registry. Outcomes included perioperative morbidity, one-year mortality and changes in left ventricular ejection fraction. Results Thirty-four patients (median [IQR] age 63.5 [52.8-71.0] years, 79.4% male) with new-onset amiodarone-induced thyrotoxicosis underwent total thyroidectomy after 68.0 [42.5–95.8] days of medical treatment. Refractory thyrotoxicosis (85.3%) and worsening heart failure (14.7%) were the main indications. At the time of surgery, 82.4% had persistent overt thyrotoxicosis. Surgical morbidity was low: one transient recurrent laryngeal nerve palsy, four cases of transient hypoparathyroidism and no bleeding or wound infection occurred. One-year mortality was 2.9%: one patient died from unrelated causes. Median preoperative left ventricular ejection fraction was 41.0 [28.3-54.4]%. Paired analysis showed no significant differences between baseline, prior to the onset of amiodarone-induced thyrotoxicosis, and postoperative left ventricular ejection fraction, though patients with preserved baseline function (≥50%) experienced a significant decline following the onset of amiodarone-induced thyrotoxicosis (p = 0.03 1 ). Conclusion Thyroidectomy represents a valuable treatment option for refractory amiodarone-induced thyrotoxicosis, with low morbidity and mortality in this cohort. Exploratory analyses indicate that left ventricular ejection fraction remains broadly stable relative to baseline following resolution of thyrotoxicosis. However, in patients with preserved baseline ejection fraction, cardiac function declined significantly during the thyrotoxic state.

Frontiers in EndocrinologyVol. 17
Kantonsspital St. Gallen (CH), OST - Ostschweizer Fachhochschule (CH), Ostschweizer Kinderspital (CH)
Good health and well-being
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon